Nordisk's, Ozempic

Novo Nordisk’s CEO is out after the Ozempic maker’s stock dropped 50% in a year

Posted on by Zonia Catt
Novo Nordisk’s CEO is out after the Ozempic maker’s stock dropped 50% in a year
21
May

Novo Nordisk (NVO) CEO Lars Fruergaard Jørgensen will step down after eight years at the helm of the Danish pharmaceutical giant responsible for the blockbuster drugs Ozempic and Wegovy, the company said Friday.Read more…
Read More

Leave a Reply

You were not leaving your cart just like that, right?

Enter your details below to save your shopping cart for later. And, who knows, maybe we will even send you a sweet discount code :)

Want to receive personalized offers?

Allow notifications to get real-time updates about your shopping cart and who knows, you may even receive a sweet discount code 😊

Maybe later